Media Campaign Launched to Raise Awareness of NARCAN® Nasal Spray

DUBLINSept. 24, 2018 /PRNewswire/ — ADAPT Pharma (ADAPT) today launched a pilot media campaign in eight designated market areas in the U.S. to increase awareness of the life-saving potential of NARCAN® (naloxone HCl) Nasal Spray 4mg for people in the community who may witness an accidental opioid overdose. Friends and family members are encouraged to be prepared to respond to an opioid emergency by obtaining NARCAN® Nasal Spray, which is covered by most health insurance and available from major retail pharmacies without a prescription from a doctor.